Ad
related to: anticancer research scimago
Search results
Results From The WOW.Com Content Network
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, [5] originated from a research group at the University of Granada. The SJR indicator is a variant of the eigenvector centrality measure used in network theory. Such measures establish the importance of a node in a network based on ...
The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers. [1] It is related to the journal Current Medicinal Chemistry and was established in 2001 as Current Medicinal Chemistry – Anti-Cancer Agents. [2]
Journal ranking is widely used in academic circles in the evaluation of an academic journal's impact and quality. Journal rankings are intended to reflect the place of a journal within its field, the relative difficulty of being published in that journal, and the prestige associated with it.
The SCImago Institutions Rankings (SIR) [1] since 2009 has published its international ranking of worldwide research institutions, the SIR World Report. [2] The SIR World Report is the work of the SCImago Research Group, [3] a Spain-based research organization consist of members from the Spanish National Research Council (CSIC), University of Granada, Charles III University of Madrid ...
It covers research on all aspects of cancer and cancer-related biomedical sciences and was established in 1941. The editor-in-chief is Chi Van Dang. [1] The journal was established in 1916 as the Journal of Cancer Research, was renamed American Journal of Cancer in 1931, and obtained its current name in 1941.
Tumor markers may be used for the following purposes: Monitoring the malignancy; When a malignant tumor is found by the presence of a tumor marker, the level of marker found in the body can be monitored to determine the state of the tumor and how it responds to treatment.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics.